Stay updated on Canagliflozin Impact on Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.

Latest updates to the Canagliflozin Impact on Heart Failure Clinical Trial page
- Check6 days agoChange DetectedAdded a general notice about government funding status. Updated the site revision tag from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check13 days agoChange DetectedShow glossary option added and color-coding legend updated; 'No FEAR Act Data' removed and site revision updated to v3.4.0.SummaryDifference0.8%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe history shows a new revision entry (v3.3.4) replacing the previous v3.3.3. This update is a backend revision to the page and does not modify study details or results.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the record history, and the footer now excludes the 'HHS Vulnerability Disclosure' link as well as the prior 'Revision: v3.3.2' entry.SummaryDifference0.2%

- Check77 days agoChange DetectedPage history shows the addition of Revision: v3.3.2 and the removal of Revision: v3.2.0; no substantive study content appears to be affected.SummaryDifference0.1%

- Check84 days agoChange DetectedRemoved a government funding/operating status notice from the page; the rest of the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Canagliflozin Impact on Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.